BIONTECH SE's ticker is BNTX and the CUSIP is 09075V102. A total of 285 filers reported holding BIONTECH SE in Q2 2021. The put-call ratio across all filers is 1.46 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $3,054 | -12.9% | 38 | 0.0% | 0.00% | – |
| Q1 2024 | $3,506 | -27.2% | 38 | -22.4% | 0.00% | – |
| Q4 2023 | $4,813 | -8.2% | 49 | +2.1% | 0.00% | – |
| Q3 2023 | $5,245 | +1.2% | 48 | 0.0% | 0.00% | – |
| Q2 2023 | $5,181 | -13.3% | 48 | 0.0% | 0.00% | – |
| Q1 2023 | $5,979 | +45892.3% | 48 | -43.5% | 0.00% | -100.0% |
| Q4 2022 | $13 | -99.9% | 85 | 0.0% | 0.00% | 0.0% |
| Q3 2022 | $11,000 | -47.6% | 85 | -39.3% | 0.00% | 0.0% |
| Q2 2022 | $21,000 | -19.2% | 140 | -6.7% | 0.00% | 0.0% |
| Q1 2022 | $26,000 | -88.8% | 150 | -83.4% | 0.00% | -80.0% |
| Q4 2021 | $233,000 | -14.0% | 905 | -8.9% | 0.01% | -28.6% |
| Q3 2021 | $271,000 | +2911.1% | 993 | +2382.5% | 0.01% | – |
| Q2 2021 | $9,000 | -71.0% | 40 | -87.7% | 0.00% | -100.0% |
| Q1 2021 | $31,000 | – | 325 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bill & Melinda Gates Foundation | 148,674 | $11,947,443 | 19.99% |
| Quinn Opportunity Partners LLC | 683,287 | $54,908,943 | 6.24% |
| Krensavage Asset Management, LLC | 132,293 | $10,631 | 4.88% |
| Crocodile Capital Partners GmbH | 29,586 | $2,377,531 | 3.78% |
| ALTRINSIC GLOBAL ADVISORS LLC | 676,219 | $54,340,958 | 2.42% |
| FLOSSBACH VON STORCH AG | 4,379,483 | $351,935,254 | 1.48% |
| Systrade AG | 10,000 | $803,600 | 1.38% |
| HARDING LOEVNER LP | 2,926,761 | $235,224,417 | 1.30% |
| CenterBook Partners LP | 206,234 | $16,572,964 | 1.03% |
| SECTORAL ASSET MANAGEMENT INC | 27,265 | $2,191,015 | 0.89% |